A detailed history of Coatue Management LLC transactions in Novavax Inc stock. As of the latest transaction made, Coatue Management LLC holds 2,224,319 shares of NVAX stock, worth $17.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,224,319
Previous 2,624,915 15.26%
Holding current value
$17.9 Million
Previous $33.2 Million 15.46%
% of portfolio
0.11%
Previous 0.13%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.71 - $17.11 $4.29 Million - $6.85 Million
-400,596 Reduced 15.26%
2,224,319 $28.1 Million
Q2 2024

Aug 13, 2024

BUY
$3.89 - $20.97 $4.3 Million - $23.2 Million
1,105,321 Added 72.74%
2,624,915 $33.2 Million
Q1 2024

May 14, 2024

BUY
$3.76 - $6.02 $5.71 Million - $9.15 Million
1,519,594 New
1,519,594 $7.26 Million
Q2 2023

Aug 11, 2023

SELL
$6.67 - $9.52 $4.85 Million - $6.92 Million
-726,936 Reduced 41.16%
1,039,123 $7.72 Million
Q1 2023

May 12, 2023

BUY
$5.76 - $12.48 $8.42 Million - $18.2 Million
1,462,000 Added 480.83%
1,766,059 $12.2 Million
Q4 2022

Feb 13, 2023

SELL
$8.86 - $25.04 $2.16 Million - $6.1 Million
-243,496 Reduced 44.47%
304,059 $3.13 Million
Q3 2022

Nov 10, 2022

SELL
$18.2 - $76.12 $12.6 Million - $52.8 Million
-694,161 Reduced 55.9%
547,555 $9.97 Million
Q2 2022

Aug 15, 2022

BUY
$36.28 - $75.29 $13 Million - $27 Million
358,270 Added 40.55%
1,241,716 $63.9 Million
Q1 2022

May 16, 2022

BUY
$69.73 - $142.9 $61.6 Million - $126 Million
883,446 New
883,446 $65.1 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Coatue Management LLC Portfolio

Follow Coatue Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coatue Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coatue Management LLC with notifications on news.